These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 24403239)
1. Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line. Tesfazghi S; Eide J; Dammalapati A; Korlesky C; Wyche TP; Bugni TS; Chen H; Jaskula-Sztul R Cancer Med; 2013 Oct; 2(5):734-43. PubMed ID: 24403239 [TBL] [Abstract][Full Text] [Related]
2. Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivo. Wyche TP; Dammalapati A; Cho H; Harrison AD; Kwon GS; Chen H; Bugni TS; Jaskula-Sztul R Cancer Gene Ther; 2014 Dec; 21(12):518-25. PubMed ID: 25412645 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells. Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H J Biol Chem; 2006 Dec; 281(52):39819-30. PubMed ID: 17090547 [TBL] [Abstract][Full Text] [Related]
4. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit. Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586 [TBL] [Abstract][Full Text] [Related]
5. Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells. Ning L; Greenblatt DY; Kunnimalaiyaan M; Chen H Oncologist; 2008 Feb; 13(2):98-104. PubMed ID: 18305053 [TBL] [Abstract][Full Text] [Related]
6. Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer. Truong M; Cook MR; Pinchot SN; Kunnimalaiyaan M; Chen H Ann Surg Oncol; 2011 May; 18(5):1506-11. PubMed ID: 21184191 [TBL] [Abstract][Full Text] [Related]
7. Antisurvivin oligonucleotides inhibit growth and induce apoptosis in human medullary thyroid carcinoma cells. Du ZX; Zhang HY; Gao DX; Wang HQ; Li YJ; Liu GL Exp Mol Med; 2006 Jun; 38(3):230-40. PubMed ID: 16819281 [TBL] [Abstract][Full Text] [Related]
8. Expression of the active Notch1 decreases MTC tumor growth in vivo. Jaskula-Sztul R; Pisarnturakit P; Landowski M; Chen H; Kunnimalaiyaan M J Surg Res; 2011 Nov; 171(1):23-7. PubMed ID: 21571316 [TBL] [Abstract][Full Text] [Related]
9. Salinomycin and its derivatives as potent RET transcriptional inhibitors for the treatment of medullary thyroid carcinoma. Alqahtani T; Kumarasamy VM; Huczyński A; Sun D Int J Oncol; 2020 Jan; 56(1):348-358. PubMed ID: 31746350 [TBL] [Abstract][Full Text] [Related]
10. Anti-proliferative and anti-invasive effects of ferulic acid in TT medullary thyroid cancer cells interacting with URG4/URGCP. Dodurga Y; Eroğlu C; Seçme M; Elmas L; Avcı ÇB; Şatıroğlu-Tufan NL Tumour Biol; 2016 Feb; 37(2):1933-40. PubMed ID: 26334619 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002. Kunnimalaiyaan M; Ndiaye M; Chen H Surgery; 2006 Dec; 140(6):1009-14; discussion 1014-5. PubMed ID: 17188151 [TBL] [Abstract][Full Text] [Related]
12. Leflunomide suppresses growth in human medullary thyroid cancer cells. Alhefdhi A; Burke JF; Redlich A; Kunnimalaiyaan M; Chen H J Surg Res; 2013 Nov; 185(1):212-6. PubMed ID: 23816245 [TBL] [Abstract][Full Text] [Related]
13. Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation. Giardino E; Catalano R; Barbieri AM; Treppiedi D; Mangili F; Spada A; Arosio M; Mantovani G; Peverelli E Mol Cell Endocrinol; 2019 Sep; 495():110519. PubMed ID: 31352037 [TBL] [Abstract][Full Text] [Related]
14. Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT. Baldini E; Arlot-Bonnemains Y; Sorrenti S; Mian C; Pelizzo MR; De Antoni E; Palermo S; Morrone S; Barollo S; Nesca A; Moretti CG; D'Armiento M; Ulisse S BMC Cancer; 2011 Sep; 11():411. PubMed ID: 21943074 [TBL] [Abstract][Full Text] [Related]
15. Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological induction. Jaskula-Sztul R; Eide J; Tesfazghi S; Dammalapati A; Harrison AD; Yu XM; Scheinebeck C; Winston-McPherson G; Kupcho KR; Robers MB; Hundal AK; Tang W; Chen H Mol Cancer Ther; 2015 Feb; 14(2):499-512. PubMed ID: 25512616 [TBL] [Abstract][Full Text] [Related]
16. Upregulated miR-9-3p Promotes Cell Growth and Inhibits Apoptosis in Medullary Thyroid Carcinoma by Targeting BLCAP. Chen Y; Zhang S; Zhao R; Zhao Q; Zhang T Oncol Res; 2017 Sep; 25(8):1215-1222. PubMed ID: 27938505 [TBL] [Abstract][Full Text] [Related]
17. The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth. Weinlander E; Somnay Y; Harrison AD; Wang C; Cheng YQ; Jaskula-Sztul R; Yu XM; Chen H J Surg Res; 2014 Jul; 190(1):191-7. PubMed ID: 24679699 [TBL] [Abstract][Full Text] [Related]
18. CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma. Werner TA; Forster CM; Dizdar L; Verde PE; Raba K; Schott M; Knoefel WT; Krieg A Br J Cancer; 2017 Dec; 117(12):1837-1845. PubMed ID: 29112684 [TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells. Klubo-Gwiezdzinska J; Jensen K; Costello J; Patel A; Hoperia V; Bauer A; Burman KD; Wartofsky L; Vasko V Endocr Relat Cancer; 2012 Jun; 19(3):447-56. PubMed ID: 22389381 [TBL] [Abstract][Full Text] [Related]
20. Hedgehog signaling in human medullary thyroid carcinoma: a novel signaling pathway. Bohinc B; Michelotti G; Diehl AM Thyroid; 2013 Sep; 23(9):1119-26. PubMed ID: 23410206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]